PL2274303T3 - Sposoby otrzymywania sunitynibu i jego soli - Google Patents

Sposoby otrzymywania sunitynibu i jego soli

Info

Publication number: PL2274303T3
Authority: PL; Poland
Prior art keywords: salts; processes; preparing sunitinib; sunitinib; preparing
Prior art date: 2008-03-31

Application number

PL09728114T

Other languages

English (en)

Inventor

Ettore Bigatti

Augusto Canavesi

Peter Lindsay Macdonald

Francesca Scarpitta

Original Assignee

Teva Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-31

Filing date

2009-03-31

Publication date

2013-03-29

2009-03-31 Application filed by Teva Pharma filed Critical Teva Pharma

2013-03-29 Publication of PL2274303T3 publication Critical patent/PL2274303T3/pl

Links

239000002147 L01XE04 - Sunitinib Substances 0.000 title 1
150000003839 salts Chemical class 0.000 title 1
WINHZLLDWRZWRT-ATVHPVEESA-N sunitinib Chemical compound CCN(CC)CCNC(=O)C1=C(C)NC(\C=C/2C3=CC(F)=CC=C3NC\2=O)=C1C WINHZLLDWRZWRT-ATVHPVEESA-N 0.000 title 1
229960001796 sunitinib Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL09728114T 2008-03-31 2009-03-31 Sposoby otrzymywania sunitynibu i jego soli PL2274303T3 (pl)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
US4110308P	2008-03-31	2008-03-31
US8240508P	2008-07-21	2008-07-21
US8268108P	2008-07-22	2008-07-22
US8899808P	2008-08-14	2008-08-14
US9434108P	2008-09-04	2008-09-04
US9759208P	2008-09-17	2008-09-17
US11304408P	2008-11-10	2008-11-10
EP09728114A EP2274303B1 (en)	2008-03-31	2009-03-31	Processes for preparing sunitinib and salts thereof
PCT/US2009/038934 WO2009124037A1 (en)	2008-03-31	2009-03-31	Processes for preparing sunitinib and salts thereof

Publications (1)

Publication Number	Publication Date
PL2274303T3 true PL2274303T3 (pl)	2013-03-29

Family

ID=40791224

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL09728114T PL2274303T3 (pl)	2008-03-31	2009-03-31	Sposoby otrzymywania sunitynibu i jego soli

Country Status (8)

Country	Link
US (2)	US20090247767A1 (pl)
EP (1)	EP2274303B1 (pl)
JP (1)	JP2011516488A (pl)
KR (1)	KR20100119582A (pl)
CA (1)	CA2720164A1 (pl)
ES (1)	ES2391501T3 (pl)
PL (1)	PL2274303T3 (pl)
WO (1)	WO2009124037A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20100135910A (ko) *	2008-04-16	2010-12-27	낫코 파마 리미티드	수니티닙 염기의 신규한 다형 형태
AU2010363613B2 (en)	2010-11-01	2015-02-05	Scinopharm (Kunshan) Biochemical Technology Co., Ltd.	Processes for the preparation of 3-((pyrrol-2-yl)methylene)-2-pyrrolones using 2-silyloxy-pyrroles
ES2709110T3 (es)	2012-03-23	2019-04-15	Laurus Labs Ltd	Un proceso mejorado para la preparación de sunitinib y sus sales de adición de ácido
JP6612232B2 (ja)	2013-08-28	2019-11-27	クラウンバイオサイエンスインコーポレイテッド（タイカン）	対象のマルチキナーゼ阻害剤に対する応答性を予測する遺伝子発現シグネチャ、及びその使用
CN105622680B (zh) *	2015-12-22	2018-01-19	杭州卢普生物科技有限公司	一种舒尼替尼衍生物及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR034118A1 (es) *	2000-02-15	2004-02-04	Sugen Inc	Compuestos de 2-indolinonas sustituidas con pirroles inhibidoras de proteinquinasas; sus composiciones farmaceuticas e intermediarios de sintesis
DE10023484A1 (de) *	2000-05-09	2001-11-22	Schering Ag	Anthranylamide und deren Verwendung als Arzneimittel
AR042586A1 (es) *	2001-02-15	2005-06-29	Sugen Inc	3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
DK3168218T3 (en) *	2001-08-15	2019-01-14	Pharmacia & Upjohn Co Llc	Crystalline comprising an L-malic acid salt of N- [2- (DIETHYLAMINO) ETHYL] -5 - [(5-FLUOR-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDE) METHYL] -2,4 -DIMETHYL-1H-PYRROL-3-CARBOXAMIDE FOR USE AS A MEDICINE
MXPA04003385A (es) *	2001-10-10	2005-04-11	Sugen Inc	Derivados de 3-?4-substituido con heterociclilo)-pirrol-2-ilmetilidene?-2-indolinona como inhibidores de cinasa.
CN1308326C (zh) *	2002-02-15	2007-04-04	法马西亚和厄普乔恩公司	吲哚满酮衍生物的制备方法
ES2197003B1 (es) *	2002-04-08	2005-03-16	J. URIACH & CIA S.A.	Nuevos compuestos antagonistas de integrinas alfa.
US7494997B2 (en) *	2002-06-28	2009-02-24	Nippon Shinyaku Co., Ltd.	Amide derivative
US7427611B2 (en) *	2003-09-26	2008-09-23	Solvay Pharmaceuticals Gmbh	Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
US20060009510A1 (en) *	2004-07-09	2006-01-12	Pharmacia & Upjohn Company Llc	Method of synthesizing indolinone compounds
US8026237B2 (en) *	2004-07-30	2011-09-27	Exelixis, Inc.	Pyrrole derivatives as pharmaceutical agents
CA2593156C (en) *	2005-01-10	2015-05-05	Exelixis, Inc.	Heterocyclic carboxamide compounds as steroid nuclear receptors ligands
CA2635360A1 (en) *	2005-12-29	2007-07-19	The Scripps Research Institute	Amino acid derivatives of indolinone based protein kinase inhibitors
EP2220072A2 (en) *	2007-11-21	2010-08-25	Teva Pharmaceutical Industries Ltd.	Polymorphs of sunitinib base and processes for preparation thereof

2009
- 2009-03-31 PL PL09728114T patent/PL2274303T3/pl unknown
- 2009-03-31 ES ES09728114T patent/ES2391501T3/es active Active
- 2009-03-31 JP JP2011503093A patent/JP2011516488A/ja active Pending
- 2009-03-31 US US12/415,352 patent/US20090247767A1/en not_active Abandoned
- 2009-03-31 CA CA2720164A patent/CA2720164A1/en not_active Abandoned
- 2009-03-31 WO PCT/US2009/038934 patent/WO2009124037A1/en not_active Ceased
- 2009-03-31 KR KR1020107021937A patent/KR20100119582A/ko not_active Ceased
- 2009-03-31 EP EP09728114A patent/EP2274303B1/en not_active Not-in-force
2010
- 2010-03-04 US US12/717,481 patent/US20100160646A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP2274303B1 (en)	2012-08-29
WO2009124037A1 (en)	2009-10-08
US20090247767A1 (en)	2009-10-01
US20100160646A1 (en)	2010-06-24
KR20100119582A (ko)	2010-11-09
JP2011516488A (ja)	2011-05-26
CA2720164A1 (en)	2009-10-08
EP2274303A1 (en)	2011-01-19
ES2391501T3 (es)	2012-11-27

Publication	Publication Date	Title
IL210548A0 (en)	2011-03-31	Spiroaminodihydrothiazine derivatives
EP2173736A4 (en)	2011-03-23	PROCESS FOR PREPARING VORICONAZOLE
ZA201100799B (en)	2011-10-26	Imidazopyridin-2-one derivatives
IL210982A0 (en)	2011-04-28	Process for preparing azacytidine intermediate
LT2345410T (lt)	2021-02-25	Farmacinė kompozicija modifikuotam atpalaidavimui
IL216305A0 (en)	2012-01-31	Solid forms and process for preparing
SG10201506608RA (en)	2015-09-29	3-deazaneplanocin derivatives
IL215399A (en)	2015-11-30	Methods for making pharmaceutical ingredients
ZA201100876B (en)	2011-10-26	Pyrrolopyridinylpyrimidin-2-ylamine derivatives
PL2254887T3 (pl)	2013-05-31	Pochodne oksazolidynonu
ZA201102449B (en)	2011-12-28	Morpholinopurine derivatives
EP2416657A4 (en)	2012-09-05	COMPOUNDS COMPRISING SUBSTITUTED DI-ARYLHYDANTOIDS AND DI-ARYLTHIOHYDANTOINES AND METHODS OF USE THEREOF
IL208336A0 (en)	2010-12-30	Pyrisazinone derivatives
IL210869A0 (en)	2011-04-28	Imidazothiadiazoles derivatives
ZA201102424B (en)	2011-12-28	Process for preparing 2-alkyl-3-aroyl-5-nitro-benzofurans
IL208280A0 (en)	2010-12-30	Hydroxymethylcylohexyl amines
ZA201100948B (en)	2012-04-25	Acylaminobenzamide derivatives
GB0810252D0 (en)	2008-07-09	Device for preparing bone cement
ZA201105050B (en)	2012-03-28	Quinazolinamide derivatives
IL210164A0 (en)	2011-03-31	Thiazolylpiperidine derivatives
HRP20150775T1 (en)	2015-09-11	Method for preparing hypoallergens
IL208548A0 (en)	2010-12-30	2-phenyl-4-cyclopropyl-pyrimidine derivatives
IL208991A0 (en)	2011-01-31	Imidazolidine derivatives
IL208514A0 (en)	2010-12-30	Process for preparing substituted biphenylanilides
GB0816577D0 (en)	2008-10-15	Growth factor